Who are Vedere's investors?

Vedere's investors include Mission Bay Capital, Mission Biocapital.

Where is Vedere headquartered?

Vedere is headquartered in Cambridge, US.

Vedere

Cambridge, US · 2 known investors

Find your way into Vedere

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vedere team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.

Biotech Deep Tech Medical Devices

Investors · 2

Mission Bay Capitallisted by Mission Bay CapitalSan Francisco

Mission Biocapitallisted by Mission BiocapitalSan Francisco · $500K

How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does Vedere do?: Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.
Who are Vedere's investors?: Vedere's investors include Mission Bay Capital, Mission Biocapital.
Where is Vedere headquartered?: Vedere is headquartered in Cambridge, US.